Generated by GPT-5-mini| Nature Portfolio | |
|---|---|
| Name | Nature Portfolio |
| Type | Subsidiary |
| Industry | Publishing |
| Founded | 1869 |
| Founder | Joseph Norman Lockyer |
| Headquarters | London |
| Owner | Springer Nature |
| Products | Scientific journals, magazines, websites |
Nature Portfolio is a global publisher of scientific and medical content comprising journals, magazines, and online platforms. It traces its origins to the 19th century and today sits within a multinational publishing group, producing flagship titles alongside specialized periodicals. The organization interacts with a wide network of researchers, institutions, funders, and indexing services across continents.
Nature Portfolio originated from the establishment of Nature in 1869 by Joseph Norman Lockyer and contemporaries in London. Throughout the 19th and 20th centuries it intersected with figures such as Charles Darwin, Louis Pasteur, Dmitri Mendeleev, James Clerk Maxwell, Alfred Nobel, and institutions like the Royal Society, Cambridge University, University of Oxford, and Imperial College London. In the 20th century editorial leadership engaged with events including the World War I, the Great Depression, and the World War II, shaping science communication during crises involving agencies such as the National Institutes of Health and Max Planck Society. Postwar expansion paralleled growth of organizations like NASA, European Space Agency, Atomic Energy Commission, and universities such as Harvard University, Stanford University, Massachusetts Institute of Technology, University of California, Berkeley and Princeton University. Corporate consolidations in the 21st century involved entities including Macmillan Publishers, Holtzbrinck Publishing Group, Springer Science+Business Media, and culminated in ownership by Springer Nature, with strategic alignments alongside publishers like Wiley-Blackwell, Elsevier, Taylor & Francis, and SAGE Publications.
The portfolio includes flagship and specialist publications such as Nature, discipline-specific titles akin to Nature Genetics, Nature Medicine, Nature Neuroscience, Nature Materials, Nature Physics, Nature Chemistry, Nature Biotechnology, Nature Climate Change, Nature Communications, and subject journals comparable to The Lancet, Cell, Science, Proceedings of the National Academy of Sciences, The BMJ, JAMA, PNAS, and Nature Reviews Genetics. Complementary magazines and online outlets echo formats found in Scientific American, New Scientist, The New York Times science section, and platforms like arXiv, bioRxiv, medRxiv, PubMed Central, Scopus, and Web of Science. The suite spans peer-reviewed articles, reviews, commentaries, correspondence, and editorials that engage researchers from Cold Spring Harbor Laboratory, Salk Institute, Woods Hole Oceanographic Institution, Lawrence Berkeley National Laboratory, Los Alamos National Laboratory, and health institutions such as World Health Organization and Centers for Disease Control and Prevention.
Editorial operations coordinate processes used by academic publishers such as Elsevier, Wiley, and Oxford University Press, employing peer review models paralleling those of EMBO Press and PLOS. Editorial boards recruit scholars from institutions like Yale University, Columbia University, Johns Hopkins University, University of Toronto, ETH Zurich, University of Tokyo, Peking University, and National University of Singapore. Policies address research integrity issues referenced in discussions alongside journals like Nature Biotechnology and regulatory frameworks influenced by bodies such as Committee on Publication Ethics and funders including the Wellcome Trust, Bill & Melinda Gates Foundation, European Research Council, National Science Foundation, and UK Research and Innovation. Peer review practices interact with indexing by CrossRef and identifier systems such as DOI and ORCID.
Open access initiatives align with movements represented by PLOS, Frontiers, eLife, and mandates from funders like the National Institutes of Health, Horizon Europe, and cOAlition S. Licensing options include Creative Commons frameworks similar to CC BY and CC BY-NC used across scholarly publishing. Article processing charges, transformative agreements, and read-and-publish deals intersect with institutional agents such as University of California, Max Planck Society, Wellcome Trust, UK Research Councils, and commercial partners like Springer Nature and Elsevier in negotiations over access and repository deposit policies for platforms such as PubMed Central and Europe PMC.
The business operates as part of Springer Nature, alongside imprints and units with heritage from Macmillan Publishers and Springer Science+Business Media. Corporate governance interacts with stakeholders including investment entities, academic consortia, university libraries such as Harvard Library, British Library, Library of Congress, and procurement frameworks used by consortia like Jisc and SCOAP3. Competitors and collaborators in journal portfolios include Wiley-Blackwell, Elsevier, Taylor & Francis, John Wiley & Sons, Informa (Taylor & Francis owner), and society publishers such as American Chemical Society, American Association for the Advancement of Science, and Royal Society of Chemistry.
Reputation metrics feature in comparisons with titles like Science and Cell, and are tracked by services including Journal Citation Reports, Scimago Journal Rank, Altmetric, Google Scholar, CrossRef, Scopus, and Clarivate Analytics. High-impact publications involve researchers affiliated with MIT, Caltech, University of Cambridge, University of Oxford, Imperial College London, National Institutes of Health, and Nobel laureates associated with Nobel Prize in Physiology or Medicine, Nobel Prize in Chemistry, and Nobel Prize in Physics. Debates over metrics engage communities such as the Declaration on Research Assessment and initiatives like Plan S, influencing perceptions among funders, universities, and research institutes worldwide.
Category:Academic publishing companies